Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
16 participants
INTERVENTIONAL
2019-04-25
2019-04-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Subjective Effects of Nitrous Oxide in Dental Patients - 17
NCT00000265
Effects of Combined Sevoflurane and Nitrous Oxide Inhalation - 14
NCT00000262
Nitrous Oxide Induction Induces Amnesia in Pediatric Patients
NCT02050152
Effects of Subanesthetic Concentrations of Isoflurane/Nitrous Oxide - 3
NCT00000251
Sevoflurane vs Nitrous Oxide Inhalation at Subanesthetic Concentrations - 11
NCT00000259
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group - air
Breathing air with 21 % of oxygen (0% nitrous oxide). Performing cognitive tests as per protocol.
Placebo - air
Breathing air with 21 % oxygen, no nitrous oxide.
Intervention Group - 5% nitrous oxide
Breathing 5% nitrous oxide in air with 21 % of oxygen. Performing cognitive tests as per protocol.
Nitrous Oxide
Breathing nitrous oxide, concentrations 5, 7, 10, 12, 15, 20 % in air with 21 % oxygen, in random order.
Intervention Group - 7% nitrous oxide
Breathing 7% nitrous oxide in air with 21 % of oxygen. Performing cognitive tests as per protocol.
Nitrous Oxide
Breathing nitrous oxide, concentrations 5, 7, 10, 12, 15, 20 % in air with 21 % oxygen, in random order.
Intervention Group - 10% nitrous oxide
Breathing 10% nitrous oxide in air with 21 % of oxygen. Performing cognitive tests as per protocol.
Nitrous Oxide
Breathing nitrous oxide, concentrations 5, 7, 10, 12, 15, 20 % in air with 21 % oxygen, in random order.
Intervention Group - 12% nitrous oxide
Breathing 12% nitrous oxide in air with 21 % of oxygen. Performing cognitive tests as per protocol.
Nitrous Oxide
Breathing nitrous oxide, concentrations 5, 7, 10, 12, 15, 20 % in air with 21 % oxygen, in random order.
Intervention Group - 15% nitrous oxide
Breathing 15% nitrous oxide in air with 21 % of oxygen. Performing cognitive tests as per protocol.
Nitrous Oxide
Breathing nitrous oxide, concentrations 5, 7, 10, 12, 15, 20 % in air with 21 % oxygen, in random order.
Intervention Group - 20% nitrous oxide
Breathing 20% nitrous oxide in air with 21 % of oxygen. Performing cognitive tests as per protocol.
Nitrous Oxide
Breathing nitrous oxide, concentrations 5, 7, 10, 12, 15, 20 % in air with 21 % oxygen, in random order.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nitrous Oxide
Breathing nitrous oxide, concentrations 5, 7, 10, 12, 15, 20 % in air with 21 % oxygen, in random order.
Placebo - air
Breathing air with 21 % oxygen, no nitrous oxide.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* allergy to nitrous oxide
* severe asthma or other severe respiratory conditions
* severe cardiovascular conditions
18 Years
30 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Czech Technical University in Prague
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Karel Roubik, prof., Ph.D.
Role: STUDY_DIRECTOR
Czech Technical University in Prague
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Czech Technical University
Prague, , Czechia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VentRes-2019-02-KR
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.